0 291

Cited 0 times in

Effects of cyclocreatine in rat hepatocarcinogenesis model

DC Field Value Language
dc.contributor.author이윤실-
dc.date.accessioned2019-11-11T05:01:38Z-
dc.date.available2019-11-11T05:01:38Z-
dc.date.issued2000-
dc.identifier.issn0250-7005-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/171551-
dc.description.abstractCyclocreatine (CCr), a substrate analogue of creatine kinase (CK: EC 2.7.3.2.), exhibits anti-tumor activity in vitro and in vivo. We examined the effects of CCr on the hepatocarcinogenesis of F344 rats caused by treatment with diethylnitrosamine (DEN), partial hepatectomy (PH) or 2-acetylaminofluorene (2-AAF). The rats were given a single intraperitoneal injection of 200 mg of DEN per kg in 0.85% NaCl solution at four weeks of age. Two weeks later they were divided into two groups. One group was continuously fed a commercial powder diet containing 0.02% 2-AAF for 12 weeks and the other was continuously fed a commercial powder diet containing 1% CCr plus 0.02% 2-AAF for 12 weeks. A third group of rats as a control was given only a normal powder diet for 12 weeks. All the groups were subjected to a two-thirds partial hepatectomy (PH) at 3 weeks under avertin anesthesia. To elucidate the inhibitory effect of CCr on chemical induced hepatocarcinogenesis, we examined not only the distribution of glutathione-S-transferase placental form (GST-P) a marker used for tumorigenesis, but also the inhibition of the degree of apoptosis. The number (No./cm2) and area (mm2/cm2) of GST-P positive liver foci were significantly lower in the 2-AAF + CCr treated when compared to the group treated with 2-AAF only. Our data suggest that CCr inhibits the degrees of GST-P-positive cells and apoptosis and is active against hepatocarcinogenesis in rat models. This result points out the unique nature of an anticancer agent that inhibits progression of chemically induced hepatocarcinogenesis of rats.-
dc.description.statementOfResponsibilityprohibition-
dc.languageEnglish-
dc.publisherInternational Institute of Anticancer Research-
dc.relation.isPartOfAnticancer Research-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAnimals-
dc.subject.MESHAntineoplastic Agents/toxicity*-
dc.subject.MESHApoptosis-
dc.subject.MESHCell Transformation, Neoplastic/chemically induced*-
dc.subject.MESHCreatinine/analogs & derivatives*-
dc.subject.MESHCreatinine/toxicity*-
dc.subject.MESHDisease Models, Animal-
dc.subject.MESHFemale-
dc.subject.MESHHyperplasia/etiology-
dc.subject.MESHImmunohistochemistry-
dc.subject.MESHLiver Neoplasms, Experimental/etiology*-
dc.subject.MESHLiver Neoplasms, Experimental/pathology-
dc.subject.MESHRats-
dc.subject.MESHRats, Inbred F344-
dc.titleEffects of cyclocreatine in rat hepatocarcinogenesis model-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiation Oncology (방사선종양학교실)-
dc.contributor.googleauthorJeong KS-
dc.contributor.googleauthorPark SJ-
dc.contributor.googleauthorLee CS-
dc.contributor.googleauthorKim TW-
dc.contributor.googleauthorKim SH-
dc.contributor.googleauthorRyu SY-
dc.contributor.googleauthorWilliams BH-
dc.contributor.googleauthorVeech RL-
dc.contributor.googleauthorLee YS-
dc.contributor.localIdA03021-
dc.relation.journalcodeJ00188-
dc.identifier.eissn1791-7530-
dc.identifier.pmid10928082-
dc.contributor.alternativeNameLee, Yun Sil-
dc.contributor.affiliatedAuthor이윤실-
dc.citation.volume20-
dc.citation.number3A-
dc.citation.startPage1627-
dc.citation.endPage1633-
dc.identifier.bibliographicCitationAnticancer Research, Vol.20(3A) : 1627-1633, 2000-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.